CUSIP: 91822J202
Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
2,901,787
-
Share change
-
+52,014
-
Total reported value
-
$1,708,073
-
Put/Call ratio
-
0.01%
-
Price per share
-
$0.59
-
Number of holders
-
36
-
Value change
-
+$24,462
-
Number of buys
-
9
-
Number of sells
-
14
Quarterly Holders Quick Answers
What is CUSIP 91822J202?
CUSIP 91822J202 identifies VBIVQ - VBI VACCINES INC CDA - COM NEW in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2024
-
Previous quarter:
Q3 2023
Recent filing periods for CUSIP 91822J202:
Institutional Holders of VBI VACCINES INC CDA - COM NEW (VBIVQ) as of Q4 2023
As of 31 Dec 2023,
VBI VACCINES INC CDA - COM NEW (VBIVQ) was held by
36 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,901,787 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, Alyeska Investment Group, L.P., VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., Cambridge Investment Research Advisors, Inc., CITADEL ADVISORS LLC, RENAISSANCE TECHNOLOGIES LLC, NORTHERN TRUST CORP, and MORGAN STANLEY.
This page lists
36
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.